Autophagy by glycolysis, lipid metabolism, and glutamine in glioma
Regulation of autophagy by glycolysis, lipid metabolism, and glutamine in glioma. Autophagy could be regulated by Hexokinase2 (HK2), which directly binds and inhibits the mammalian target of rapamycin complex1 (mTORC1) leading to autophagy. Phosphofructo-2-kinase/fructose-2,6-biphosphatase3 (PFKFB3) induces autophagy by phosphorylating at 5′AMP-activated protein kinase (AMPK); glyceraldehyde 3-Phosphate dehydrogenase (GA3PDH) inhibits mTOR by binding to Rheb. PGK1 activates Beclin1 and induces autophagy; pyruvate kinase (PMK2) activates autophagy by inhibiting phosphorylation at AKT1 substrate 1 (AKT1S1) a mTORC1 inhibitor. Fatty acid synthase (FASN) inhibits hypoxia-inducible factor-1 α (HIF-1α) and transcription factor EB (TFEB), Ceramide (Ce) induces autophagy by activating at c-Jun N-terminal kinase (JNK)/c-Jun pathway. Omega-3-polyunsaturated fatty acids (ω3-PUFAS) activate at AMPK; Phosphoinositides (3,4,5)triphosphate (PtdIns (3,4,5) P3) activate at mTOR. Hydroxymethylglutaryl-coenzyme A reductase (HMGCR) activates at AMPK. Abbreviations, leucine (leu)Glutamine synthetase, glutamine (Gln), glutamate (Glu), Glutaminase (GLS), Glutamate dehydrogenase (GDH), Glutamine transport via alanine/serine/cysteine transporter 2 (ASCT2), glutathione (GSH), Forkhead box O (FOXO). ↑ activation, ⊥ inhibition. The figure was created with BioRender.com
Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma (2023)
Cristina Trejo-Solis, et al. Int J Mol Sci. 2023 Dec;24(24). Figure: F4.